Contact Medicinal Tirzepatide

Editorial contact

Medicinal Tirzepatide is an editorial project. We accept correspondence on the following:

— Corrections to citations or factual claims (include the page URL, the claim in question, and the correcting source with its PMID or DOI). — Citation errors or broken reference links. — Questions about the scope or methodology of this digest.

We do not provide medical advice. We are not a clinic. We cannot assist with prescriptions, dosing recommendations, treatment decisions, or product sourcing. For questions about tirzepatide as a medical treatment, consult a licensed healthcare provider.

Editorial disclaimer

This site publishes editorial summaries of publicly available peer-reviewed research. Content on this site does not constitute medical advice, a clinical recommendation, or an endorsement of any compound for human use. Every quantitative claim is cited to a primary source; citations are indexed at /references.

Timelines in the research record: the SURPASS and SURMOUNT literature is active and expanding. New trial results, safety surveillance findings, and pharmacokinetic sub-studies are published regularly. This digest reflects the literature as of its most recent update. Check the references index for publication years.